Skip to main content
. Author manuscript; available in PMC: 2023 Apr 12.
Published in final edited form as: J Am Coll Cardiol. 2022 Apr 12;79(14):1398–1406. doi: 10.1016/j.jacc.2021.11.065

Table 3.

Diagnostic Testing in Women

Utilization Limitations Sensitivity & Specificity*
Coronary artery calcium scoring • Predictors of subclinical CHD particularly in women
• Risk stratify women with an intermediate FRS
Sensitivity 95%
Specificity 66%
Exercise treadmill testing • Initial diagnostic test for symptomatic women, capable of exercising • Uninterpretable ECG
• Exercise limitation
Sensitivity 61%
Specificity 70%
Dobutamine stress echocardiography • Identification of obstructive CAD and estimation of prognosis in premenopausal woman
• Detection of obstructive CAD and risk among symptomatic women with intermediate to high IHD risk
• Image artifacts due to respiration and patient habitus/motion Sensitivity 80%
Specificity 84%
Exercise stress echocardiography • Identification of obstructive CAD and estimation of prognosis for symptomatic women at intermediate-high IHD risk and with any of the following: (a) resting ST-segment abnormalities, (b) functional disability, or (c) indeterminate or intermediate-risk stress ECG
• Diastolic function and pulmonary artery pressures may be reasonable in the echocardiographic evaluation of women presenting with dyspnea
• Exercise limitation
• Image artifacts due to respiration and patient habitus/motion
Sensitivity 79%
Specificity 83%
Single-photon emission tomography (SPECT) myocardial perfusion imaging (MPI) exercise • Symptomatic women at intermediate-high IHD risk and with (a) resting ST-segment abnormalities, (b) functional disability, or (c) indeterminate or intermediate-risk stress ECG, stress MPI with SPECT or PET is recommended for identification of obstructive CAD and estimation of prognosis
• Symptomatic women with an intermediate-high IHD risk who also have abnormal rest ST-segment changes or functional disability
• Radiation exposure
• Dense breast and obesity reduce specificity
• Lower cardiac mass in women causing lower sensitivity for ischemia and inaccurate TID
Sensitivity 82%
Specificity 81%
Pharmacological stress myocardial perfusion imaging (MPI) Sensitivity 93%
Specificity 78%
Stress positron emission tomography (PET) • Symptomatic women at intermediate-high IHD risk and with (a) resting ST-segment abnormalities, (b) functional disability, or (c) indeterminate or intermediate-risk stress ECG, stress MPI with SPECT or PET is
recommended for identification of obstructive CAD and estimation of prognosis
• Extent and severity of myocardial perfusion and wall-motion abnormalities, as well as LVEF assessment at rest and after stress.
• Calculate absolute blood flow across the coronary vessels, which leads to the calculation of PET MFR, aid in the detection of microvascular CAD
• Ability to quantify myocardial blood flow and coronary flow reserve to diagnose ischemia, even in the absence of obstructive CAD
Sensitivity 90%
Specificity 89%
Stress cardiac magnetic resonance (CMR) • Premenopausal woman with functional disability
• Symptomatic women at intermediate-high IHD risk and with (a) resting ST-segment abnormalities, (b) functional disability, or (c) indeterminate or intermediate risk, it may be reasonable to use stress CMR, especially vasodilator stress
• Perfusion CMR, as the index procedure within the diagnostic evaluation
• Assessment of subendocardial perfusion
Sensitivity 89%
Specificity 80%
Coronary CTA • Detailed anatomical information and has a high diagnostic and prognostic accuracy for the detection of CHD
• Risk stratification of women after an indeterminate stress test, also for women with persistent symptoms despite a negative stress test
• Poor predictors of the hemodynamic significance of CAD Sensitivity 96%
Specificity 92%